Dose-dependent severe cutaneous reactions to imatinib

The protein kinase inhibitor imatinib has been approved as an efficient anticancer drug with common but mild cutaneous toxicities. We here report on two out of four melanoma patients treated with high-dose imatinib presenting with severe and strongly dose-dependent skin eruptions, suggesting a cutan...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer Vol. 88; no. 8; pp. 1157 - 1159
Main Authors: UGUREL, S, HILDENBRAND, R, DIPPER, E, HOCHHAUS, A, SCHADENDORF, D
Format: Journal Article
Language:English
Published: Basingstoke Nature Publishing Group 22-04-2003
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The protein kinase inhibitor imatinib has been approved as an efficient anticancer drug with common but mild cutaneous toxicities. We here report on two out of four melanoma patients treated with high-dose imatinib presenting with severe and strongly dose-dependent skin eruptions, suggesting a cutaneous reactivity pattern different from allergic hypersensitivity.
AbstractList The protein kinase inhibitor imatinib has been approved as an efficient anticancer drug with common but mild cutaneous toxicities. We here report on two out of four melanoma patients treated with high-dose imatinib presenting with severe and strongly dose-dependent skin eruptions, suggesting a cutaneous reactivity pattern different from allergic hypersensitivity.
Author HILDENBRAND, R
SCHADENDORF, D
UGUREL, S
HOCHHAUS, A
DIPPER, E
Author_xml – sequence: 1
  givenname: S
  surname: UGUREL
  fullname: UGUREL, S
  organization: Skin Cancer Unit, German Cancer Research Center, 69120 Heidelberg, Germany
– sequence: 2
  givenname: R
  surname: HILDENBRAND
  fullname: HILDENBRAND, R
  organization: Institute of Pathology, University Hospital of Mannheim, 68167 Mannheim, Germany
– sequence: 3
  givenname: E
  surname: DIPPER
  fullname: DIPPER, E
  organization: Department of Dermatology, University Hospital of Mannheim, 68167 Mannheim, Germany
– sequence: 4
  givenname: A
  surname: HOCHHAUS
  fullname: HOCHHAUS, A
  organization: Department of Internal Medicine, University Hospital of Mannheim, 68167 Mannheim, Germany
– sequence: 5
  givenname: D
  surname: SCHADENDORF
  fullname: SCHADENDORF, D
  organization: Skin Cancer Unit, German Cancer Research Center, 69120 Heidelberg, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14754229$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12698177$$D View this record in MEDLINE/PubMed
BookMark eNpVkM1LwzAYh4NMdJtevSlF8NiZj-ajF0H8hoEXPYc0factWzKTduB_b2R1KjmEJE9-78NvgkbOO0DohOAZwUxdxnZWtXYmBMaqZHtoTDijOVFUjtAYYyxzXFJ8iCYxtulYYiUP0CGholREyjHitz5CXsMaXA2uyyJsIEBm-8448H3MAhjbNd7FrPNZszJd45rqCO0vzDLC8bBP0ev93cvNYz5_fni6uZ7nthC8y0spyrqwnBtZF1VVFVhYoRRLN4xgkIYaLKSyihCJSSUNUTW1jNYVKMFLzqboapu77qsV1DYZBrPU65BEwqf2ptH_X1zzrt_8RlNZSM7LFHA-BAT_0UPsdOv74JKzpiz1wWRaUzTbQjb4GAMsdgMI1t8t69jq1LIeWk4fzv5q_eJDrQm4GAATrVkugnG2ib9ckiso_dY73XLOdH2AHfAz6Au3xZFU
CODEN BJCAAI
CitedBy_id crossref_primary_10_1007_s00105_008_1540_0
crossref_primary_10_1007_s11654_008_0106_x
crossref_primary_10_1016_j_ejps_2017_12_003
crossref_primary_10_5021_ad_2013_25_4_500
crossref_primary_10_1111_j_1610_0387_2008_06831_x
crossref_primary_10_1111_j_1346_8138_2007_00369_x
crossref_primary_10_3390_biomedicines9010002
crossref_primary_10_1016_j_yadr_2005_03_002
crossref_primary_10_1158_1078_0432_CCR_03_0155
crossref_primary_10_1016_S0755_4982_06_74539_0
crossref_primary_10_1007_s40257_023_00790_8
crossref_primary_10_1016_j_piel_2016_06_010
crossref_primary_10_1016_S0213_9251_08_71008_6
crossref_primary_10_1007_s00105_009_1754_9
crossref_primary_10_1007_s00761_008_1548_1
crossref_primary_10_1002_pds_933
crossref_primary_10_1345_aph_1H304
crossref_primary_10_12771_emj_2012_35_2_76
crossref_primary_10_1038_sj_bjc_6602529
crossref_primary_10_1111_j_1440_0960_2007_00384_x
crossref_primary_10_1111_ijd_13111
crossref_primary_10_1111_pde_12380
crossref_primary_10_1136_bcr_2019_232263
crossref_primary_10_1111_ijd_13852
Cites_doi 10.1056/NEJM200104053441401
10.1097/00008390-199602000-00004
10.1182/blood.V99.10.3530
10.1056/NEJMoa020461
10.1056/NEJMoa011573
10.1182/blood.V99.5.1741
10.1182/blood.V99.6.1928
10.1016/S0140-6736(01)06535-7
10.1056/NEJM200108233450814
ContentType Journal Article
Copyright 2003 INIST-CNRS
Copyright Nature Publishing Group Apr 22, 2003
Copyright © 2003 Cancer Research UK 2003 Cancer Research UK
Copyright_xml – notice: 2003 INIST-CNRS
– notice: Copyright Nature Publishing Group Apr 22, 2003
– notice: Copyright © 2003 Cancer Research UK 2003 Cancer Research UK
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7TO
7U9
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOI 10.1038/sj.bjc.6600893
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
British Nursing Database
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList ProQuest Central Student
MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Cutaneous reactions to imatinib
EISSN 1532-1827
EndPage 1159
ExternalDocumentID 984016521
10_1038_sj_bjc_6600893
12698177
14754229
6600893
Genre Journal Article
Case Reports
Report
Case Study
GroupedDBID -
-Q-
02
08R
0R
23N
39C
3V.
4.4
53G
55
5GY
5RE
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
AADWK
AAPBV
AAWBL
AAWTL
AAYJO
AAZLF
ABAWZ
ABDBF
ABDEU
ABFLS
ABGIJ
ABOCM
ABPTK
ABUWG
ACGFS
ACKTT
ACPRK
ADACO
ADBBV
ADHDB
ADQMX
AEDAW
AEJRE
AENEX
AFKRA
AFRAH
AFSHS
AGEZK
AHMBA
AHSBF
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AN0
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BAWUL
BBAFP
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BNQBC
BPHCQ
BVXVI
CAG
COF
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EPL
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRJ
FSGXE
FYUFA
GX1
HCIFZ
HVGLF
HYE
HZ
IH2
J5H
JSO
KQ8
M1P
M7P
NAO
NAPCQ
O9-
OK1
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q-
Q2X
RIG
RNT
RNTTT
RPM
SNX
SNYQT
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
TUS
UDS
VH1
W2D
WH7
WOW
X7M
XFK
ZA5
ZGI
---
.55
.GJ
0R~
36B
406
6J9
70F
8WZ
A6W
AANZL
AATNV
AAUGY
AAYFA
ABLJU
ACBMV
ACBRV
ACBYP
ACGFO
ACIGE
ACRQY
ACTTH
ACVWB
ADFRT
ADMDM
ADYYL
AEFTE
AEVLU
AEXYK
AFNRJ
AGAYW
AGGBP
AGHAI
AI.
AILAN
AJCLW
AJDOV
AMRJV
AMYLF
AOIJS
CCPQU
DNIVK
DPUIP
EMOBN
HZ~
IQODW
IWAJR
JZLTJ
M41
NQJWS
NYICJ
SOHCF
SRMVM
UKHRP
Y6R
~02
~8M
AAYZH
ABAKF
ABZZP
ACAOD
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
CGR
CUY
CVF
ECM
EIF
HMCUK
NPM
AAYXX
CITATION
7TO
7U9
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
LK8
5PM
ID FETCH-LOGICAL-c465t-9769d4c55a7d4bbb406c6883c55310e7a2a0678c811701b7a18d2c32dbe865953
IEDL.DBID RPM
ISSN 0007-0920
IngestDate Tue Sep 17 21:06:09 EDT 2024
Wed Nov 06 08:54:57 EST 2024
Thu Sep 26 19:54:07 EDT 2024
Tue Oct 15 23:29:08 EDT 2024
Sun Oct 22 16:05:10 EDT 2023
Thu Oct 07 19:33:34 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Antineoplastic agent
Human
Skin disease
Imatinib
Enzyme
Toxicity
c-kit
Transferases
Exanthema
Melanoma
Enzyme inhibitor
Malignant tumor
mast cells
Dose activity relation
Chemotherapy
Treatment
adverse drug reaction
Complication
Advanced stage
High dose
Protein-tyrosine kinase
Language English
License CC BY 4.0
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-9769d4c55a7d4bbb406c6883c55310e7a2a0678c811701b7a18d2c32dbe865953
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747559/
PMID 12698177
PQID 230003737
PQPubID 41855
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2747559
proquest_journals_230003737
crossref_primary_10_1038_sj_bjc_6600893
pubmed_primary_12698177
pascalfrancis_primary_14754229
nature_primary_6600893
ProviderPackageCode ABDEU
AEDAW
AAZLF
-Q-
AADWK
AAYJO
ADQMX
EE.
RNTTT
SWTZT
ABGIJ
RNT
NAO
PublicationCentury 2000
PublicationDate 2003-04-22
PublicationDateYYYYMMDD 2003-04-22
PublicationDate_xml – month: 04
  year: 2003
  text: 2003-04-22
  day: 22
PublicationDecade 2000
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
– name: London
PublicationTitle British journal of cancer
PublicationTitleAlternate Br J Cancer
PublicationYear 2003
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References Kantarjian, H, Sawyers, C, Hochhaus, A, Guilhot, F, Schiffer, C, Gambacorti-Passerini, C, Niederwieser, D, Resta, D, Capdeville, R, Zoellner, U, Talpaz, M, Druker, B, Goldman, J, O'Brien, SG, Russell, N, Fischer, T, Ottmann, O, Cony-Makhoul, P, Facon, T, Stone, R, Miller, C, Tallman, M, Brown, R, Schuster, M, Loughran, T, Gratwohl, A, Mandelli, F, Saglio, G, Lazzarino, M, Russo, D, Baccarani, M, Morra, E 2002; 346
Ma, Y, Zeng, S, Metcalfe, DD, Akin, C, Dimitrijevic, S, Butterfield, JH, McMahon, G, Longley, BJ 2002; 99
Sawyers, CL, Hochhaus, A, Feldman, E, Goldman, JM, Miller, CB, Ottmann, OG, Schiffer, CA, Talpaz, M, Guilhot, F, Deininger, MW, Fischer, T, O'Brien, SG, Stone, RM, Gambacorti-Passerini, CB, Russell, NH, Reiffers, JJ, Shea, TC, Chapuis, B, Coutre, S, Tura, S, Morra, E, Larson, RA, Saven, A, Peschel, C, Gratwohl, A, Mandelli, F, Ben-Am, M, Gathmann, I, Capdeville, R, Paquette, RL, Druker, BJ 2002; 99
van Oosterom, AT, Judson, I, Verweij, J, Stroobants, S, Donato di Paola, E, Dimitrijevic, S, Martens, M, Webb, A, Sciot, R, Van Glabbeke, M, Silberman, S, Nielsen, OS 2001; 358
Brouard, M, Saurat, JH 2001; 345
Talpaz, M, Silver, RT, Druker, BJ, Goldman, JM, Gambacorti-Passerini, C, Guilhot, F, Schiffer, CA, Fischer, T, Deininger, MW, Lennard, AL, Hochhaus, A, Ottmann, OG, Gratwohl, A, Baccarani, M, Stone, R, Tura, S, Mahon, FX, Fernandes-Reese, S, Gathmann, I, Capdeville, R, Kantarjian, HM, Sawyers, CL 2002; 99
Druker, BJ, Talpaz, M, Resta, DJ, Peng, B, Buchdunger, E, Ford, JM, Lydon, NB, Kantarjian, H, Capdeville, R, Ohno-Jones, S, Sawyers, CL 2001; 344
Demetri, GD, von Mehren, M, Blanke, CD, van den Abbeele, AD, Eisenberg, B, Roberts, PJ, Heinrich, MC, Tuveson, DA, Singer, S, Janicek, M, Fletcher, JA, Silverman, SG, Silberman, SL, Capdeville, R, Kiese, B, Peng, B, Dimitrijevic, S, Druker, BJ, Corless, C, Fletcher, CD, Joensuu, H 2002; 347
Ohashi, A, Funasaka, Y, Ueda, M, Ichihashi, M 1996; 6
11287972 - N Engl J Med. 2001 Apr 5;344(14):1031-7
12181401 - N Engl J Med. 2002 Aug 15;347(7):472-80
11529225 - N Engl J Med. 2001 Aug 23;345(8):618-9
11877262 - Blood. 2002 Mar 15;99(6):1928-37
11986204 - Blood. 2002 May 15;99(10):3530-9
11705489 - Lancet. 2001 Oct 27;358(9291):1421-3
8640066 - Melanoma Res. 1996 Feb;6(1):25-30
11870241 - N Engl J Med. 2002 Feb 28;346(9):645-52
11861291 - Blood. 2002 Mar 1;99(5):1741-4
A Ohashi (BF6600893_CR6) 1996; 6
CL Sawyers (BF6600893_CR7) 2002; 99
M Talpaz (BF6600893_CR8) 2002; 99
M Brouard (BF6600893_CR1) 2001; 345
BJ Druker (BF6600893_CR3) 2001; 344
AT van Oosterom (BF6600893_CR9) 2001; 358
H Kantarjian (BF6600893_CR4) 2002; 346
Y Ma (BF6600893_CR5) 2002; 99
GD Demetri (BF6600893_CR2) 2002; 347
References_xml – volume: 345
  start-page: 618
  year: 2001
  end-page: 619
  article-title: Cutaneous reactions to STI571
  publication-title: N Engl J Med
  contributor:
    fullname: Saurat, JH
– volume: 99
  start-page: 1928
  year: 2002
  end-page: 1937
  article-title: Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
  publication-title: Blood
  contributor:
    fullname: Sawyers, CL
– volume: 346
  start-page: 645
  year: 2002
  end-page: 652
  article-title: Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
  publication-title: N Engl J Med
  contributor:
    fullname: Morra, E
– volume: 347
  start-page: 472
  year: 2002
  end-page: 480
  article-title: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
  publication-title: N Engl J Med
  contributor:
    fullname: Joensuu, H
– volume: 99
  start-page: 1741
  year: 2002
  end-page: 1744
  article-title: The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
  publication-title: Blood
  contributor:
    fullname: Longley, BJ
– volume: 344
  start-page: 1031
  year: 2001
  end-page: 1037
  article-title: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
  publication-title: N Engl J Med
  contributor:
    fullname: Sawyers, CL
– volume: 6
  start-page: 25
  year: 1996
  end-page: 30
  article-title: c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi
  publication-title: Melanoma Res
  contributor:
    fullname: Ichihashi, M
– volume: 99
  start-page: 3530
  year: 2002
  end-page: 3539
  article-title: Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
  publication-title: Blood
  contributor:
    fullname: Druker, BJ
– volume: 358
  start-page: 1421
  year: 2001
  end-page: 1423
  article-title: Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
  publication-title: Lancet
  contributor:
    fullname: Nielsen, OS
– volume: 344
  start-page: 1031
  year: 2001
  ident: BF6600893_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200104053441401
  contributor:
    fullname: BJ Druker
– volume: 6
  start-page: 25
  year: 1996
  ident: BF6600893_CR6
  publication-title: Melanoma Res
  doi: 10.1097/00008390-199602000-00004
  contributor:
    fullname: A Ohashi
– volume: 99
  start-page: 3530
  year: 2002
  ident: BF6600893_CR7
  publication-title: Blood
  doi: 10.1182/blood.V99.10.3530
  contributor:
    fullname: CL Sawyers
– volume: 347
  start-page: 472
  year: 2002
  ident: BF6600893_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa020461
  contributor:
    fullname: GD Demetri
– volume: 346
  start-page: 645
  year: 2002
  ident: BF6600893_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa011573
  contributor:
    fullname: H Kantarjian
– volume: 99
  start-page: 1741
  year: 2002
  ident: BF6600893_CR5
  publication-title: Blood
  doi: 10.1182/blood.V99.5.1741
  contributor:
    fullname: Y Ma
– volume: 99
  start-page: 1928
  year: 2002
  ident: BF6600893_CR8
  publication-title: Blood
  doi: 10.1182/blood.V99.6.1928
  contributor:
    fullname: M Talpaz
– volume: 358
  start-page: 1421
  year: 2001
  ident: BF6600893_CR9
  publication-title: Lancet
  doi: 10.1016/S0140-6736(01)06535-7
  contributor:
    fullname: AT van Oosterom
– volume: 345
  start-page: 618
  year: 2001
  ident: BF6600893_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200108233450814
  contributor:
    fullname: M Brouard
SSID ssj0009087
Score 1.9462345
Snippet The protein kinase inhibitor imatinib has been approved as an efficient anticancer drug with common but mild cutaneous toxicities. We here report on two out of...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
nature
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1157
SubjectTerms Adult
Aged
Antineoplastic Agents - toxicity
Benzamides
Biological and medical sciences
Clinical
Drug Hypersensitivity - pathology
Drug toxicity and drugs side effects treatment
Female
Humans
Imatinib Mesylate
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Piperazines - toxicity
Pyrimidines - toxicity
Skin Diseases - chemically induced
Skin Diseases - pathology
Toxicity: skin, dermoskeleton
SummonAdditionalLinks – databaseName: Nature
  dbid: RNT
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwELagA0JCvAulUGVAgsUlsZ3YGRFt1YUuFIkt8iuiHZKqSf8_dl4lQCWkTLEdWXdOvu9i33cA3JugJ7YXdIUKIWFIQy5cBTl1Y40Cw-ewTU6evtHZBxuNrUzO444dfMyesuVQLOUwMMhssNV-bCkuErVm8626rstKcUz73y1Ebq3O-Gt4C30a7cyjFc-MReKylMVfXPPnkclvGDQ5-f_sT8FxxTOd53JhnIE9nZyDg9dqJ_0C-KM007AugZs7BiD1WjtyY8iiTjeZY8hkkfKQOXnqLCyvTRbiErxPxvOXKaxKKEBJAj-HhmyEikjf51QRIYSBbxkwhs0dw-s05YhbuJI23dT1BOUeU0hipIRmVmkQd0EnSRN9DRzlUY8TyZWQgiDti1h6VLsx97AKGIl74KE2bbQqlTKiYocbsyhbRsYKUWWFHuiWlm_6NQ2Dlie2zyG2UC8Ke6Bfuyaq3rUsMkGUVdHBtAeuSidtx6EgZB41LbTlvqaDFddutySLz0Jk20brJtq62TXXPjgszvW5BCJ0Czr5eqPvwH6mNoNibX4BSWXfMw
  priority: 102
  providerName: Nature Publishing
Title Dose-dependent severe cutaneous reactions to imatinib
URI http://dx.doi.org/10.1038/sj.bjc.6600893
https://www.ncbi.nlm.nih.gov/pubmed/12698177
https://www.proquest.com/docview/230003737
https://pubmed.ncbi.nlm.nih.gov/PMC2747559
Volume 88
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5cDyKI-LY-lh4ET9lt07RJj7IqK6KID_BW8iruot3F7v5_J32srngSSg9NUsqXlPkmmfkG4AydntxdJFAmJUxQS6QKDJE8yC1NkM9FLjl5-MTvX8XllZPJidtcmCpoX6tRr3j_6BWjtyq2cvqh-22cWP_hbuA8KWTC_Q50kBu2LnqrtBuIWijT7cGlNGiVGiPRL8c9Nda9BI08mmmnF0qTVIScLxmlhaTmxlSWCFReV7j4i4L-jqT8YZqut2Cz4ZT-Rf3t27Biix1Yu2tOzXchvpyUlrTlbmc-GkP7aX09R2Jo0fP3kThW6Q2lP5v4I8dhi5Hag5frq-fBkDTlEohmSTwjSCxSw3QcS26YUgpNtU6EiPAJcjjLJZXONGmXWhqEistQGKojapQVTlUw2ofVYlLYQ_BNyEPJtDRKK0ZtrHIdchvkMoxMIljuwXmLVzatVTGy6jQ7Elk5zhDkrAHZg_0azkW_RUN3Cd7v9zBXlJemHhy3eGfNf1Vm6DA5xZyIe3BQI_89rplLD_jSnCw6OCHt5RZcX5WgdrOejv498hjWqyC_gBFKT2B19jm3p9ApzbyLNP3mFu-P98_daqF-AVnD6vQ
link.rule.ids 230,315,729,782,786,887,2733,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4VKrWVEC1tgUBLc0DqybuO7cTOEfHQVmURElTiFvkVdVcluyK7_59xHguLekLKyY9I8WdrvolnvgE4RqenDA-hxuVEKOaJNtQRLWnpWYZ8jofk5NGNvLpTZ-dBJiftc2GaoH1rJoPq3_2gmvxtYivn93bYx4kNr8enwZNCJjzcgLd4XinvnfRea5eqVioz_IXLGe21Grka1tOBmdpBhmYeDXVQDGVZrhIp18zSSlRza65rXKqyrXHxPxL6MpbymXG6-PjKz_oE2x0bjU_a7h1446vP8G7c3bd_gfRsVnvSF8pdxGhG_YOP7RIppZ8t6xgpZ5MYUceLWTwJ7LeamK_w5-L89nREukILxIosXRCkJLkTNk21dMIYg0beZkpxbEH256VmOhg1G5JSaWKkTpRjljNnvAp6hHwXNqtZ5fchdolMtLDaGWsE86kpbSI9LXXCXaZEGcHPfp2LeaunUTT34FwV9bRAcIoOnAh2WxhW41YdR2uwPL1HhHK-LI_gsMep6E5kXaCrFbR2uIxgr0XsaV63ByKQa1iuBgQJ7vUehLCR4u4gO3j1zB_wfnQ7viwuf139PoQPTaggFYSxb7C5eFj677BRu-VRs8EfAQg8_ng
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Na9wwEB2aFEIhpG3aNM5XfQj0pLUsy5Z8DNksKW1CICn0ZvRlskvjXeLd_5-Rv9ItOTXgky0ZrCfx3lijNwCnGPSU_iJU25xwyRxRmlqiBC0dy1DPJf5w8uWtuP4txxfeJmco9dUk7Rs9HVV_HkbV9L7JrVw8mKjPE4turs59JIVKOFrYMtqAt7hmadoH6r3fLpWtXab_E5cz2vs1JjKqZyM9M6MMqR7J2ruGsiyXsRBr1DQYa24vVI3DVbZ1Ll4Sov_mU_5FUJP3r_i0D7DTqdLwrG3yEd64ahe2rrp990-Qjue1I33B3GWIdOoeXWhWKC3dfFWHKD2bAxJ1uJyHU6-Cq6n-DL8mF3fnl6QruEAMz9IlQWmSW27SVAnLtdZI9iaTMsE7qAKdUEx5cjP-cCqNtVCxtMwkzGonvS9hsgeb1bxy-xDaWMSKG2W10Zy5VJcmFo6WKk5sJnkZwLd-rItF66tRNPvhiSzqWYEAFR1AAey1UAzthgcna9A8v4f7sr4sD-Cwx6roVmZdYMjlPXcSEcCXFrXnft08CECs4Tk08Fbc608QxsaSu4Pt4L97foWtm_Gk-Pn9-schvGsyBiknjB3B5vJx5Y5ho7ark2aOPwEXFwEH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dose-dependent+severe+cutaneous+reactions+to+imatinib&rft.jtitle=British+journal+of+cancer&rft.au=Ugurel%2C+S&rft.au=Hildenbrand%2C+R&rft.au=Dippel%2C+E&rft.au=Hochhaus%2C+A&rft.date=2003-04-22&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=88&rft.issue=8&rft.spage=1157&rft_id=info:doi/10.1038%2Fsj.bjc.6600893&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=984016521
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon